Oura valued at $5B following deal with medical device firm Dexcom | TechCrunch
Briefly

"Ninety-seven percent of Oura Members have expressed interest in understanding how the food they eat impacts their health," said Oura CEO Tom Hale in a press release.
"Partnering with ŌURA gives us the opportunity to redefine the category again, integrating data from Dexcom glucose biosensors with the continuous insights and metrics measured by Oura Ring," said Matt Dolan, executive vice president of strategy and corporate development at Dexcom.
Read at TechCrunch
[
|
]